EGF vs. FGF-2 in skincare: which growth factor does what?
EGF (epidermal growth factor) signals keratinocytes in the epidermis, driving faster turnover, smoother surface, and stronger barrier. FGF-2 (fibroblast growth factor 2) signals fibroblasts in the dermis, driving collagen production, firmness, and wrinkle reduction. They target different layers of the skin and are most effective together.
Recombinant growth factors are some of the most studied bioactive molecules in topical skincare, but they are often discussed as a single category. They are not. EGF and FGF-2 are two distinct proteins, acting on two different cell types, and producing two different, though complementary, clinical results.
This article breaks down the biology, the published clinical evidence, and the practical formulation rules for choosing between EGF, FGF-2, or both.
What does EGF do in skin? #
EGF binds the EGF receptor on keratinocytes, the primary cells of the epidermis. It accelerates their division and migration. The downstream effects on skin are concentrated in the upper layers:
- Faster epidermal cell renewal
- Improved barrier function (reduced TEWL)
- Smoother surface texture and reduced micro-roughness
- Faster recovery after procedures such as microneedling, laser, or peels
Because the epidermis turns over in roughly 28 days, EGF-driven improvements typically show up within 2–4 weeks of consistent use.
What does FGF-2 do in skin? #
FGF-2 (also called basic FGF, or bFGF) binds receptors on fibroblasts, the collagen- and elastin-producing cells of the dermis. It stimulates fibroblast proliferation and extracellular matrix synthesis. The downstream effects are deeper and structural:
- Increased Type 1 collagen production
- Improved firmness and elasticity
- Reduction in wrinkle depth and length
- Better dermal remodeling after injury
Dermal remodeling is slower than epidermal renewal, meaningful structural change takes 4–12 weeks.
How do EGF and FGF-2 compare side by side? #
| Dimension | EGF | FGF-2 |
|---|---|---|
| Primary target cell | Keratinocytes | Fibroblasts |
| Skin layer affected | Epidermis | Dermis |
| Visible benefit | Barrier, texture, brightness | Firmness, wrinkle depth, elasticity |
| Speed of result | 2–4 weeks | 4–12 weeks |
| Best use case | Recovery, barrier repair | Anti-aging, dermal renewal |
| Typical formulation % | 0.5 – 2% | 0.5 – 2% |
| Molecular weight | ~6 kDa | ~17 kDa |
| Delivery challenge | Moderate, small but unstable | Hard, larger protein |
Should you combine EGF and FGF-2? #
Yes, when the formulation goal calls for both surface and structural improvement. EGF and FGF-2 act on different cell types via different receptors, so there is no mechanistic conflict. The combination covers both layers of the skin and tends to produce broader clinical improvement than either ingredient alone.
In our own head-to-head study, a formulation pairing 1% Peauvita™ (recombinant EGF-oleosome fusion) with 1% Peauforia™ (recombinant FGF-2-oleosome fusion) outperformed 0.3% retinol, the EU regulatory maximum, across wrinkle depth, wrinkle length, skin smoothness, and brightness, at day 30.
Why delivery matters as much as the molecule #
Both EGF and FGF-2 are large proteins relative to most cosmetic ingredients. They do not cross the stratum corneum well on their own. A formula listing EGF or FGF-2 on the INCI list is not the same as a formula delivering functional EGF or FGF-2 to the right cells.
That is why carrier systems matter. We grow recombinant EGF and FGF-2 fused to the surface of oleosomes , native plant lipid droplets, which provides both stabilization and biomimetic delivery into the skin. Other valid approaches include liposomes, peptide-tagged variants, and microemulsions; the principle is the same: large proteins need a carrier to work.
Best for / Not ideal for #
- Anti-aging serums (FGF-2 especially)
- Post-procedure recovery (EGF especially)
- Barrier repair after compromise (EGF)
- Premium anti-wrinkle creams (combined EGF + FGF-2)
- Sensitive-skin alternatives to retinol
- Simple cleansers or rinse-off products
- Pure hydration formulas (no benefit over hyaluronic acid)
- Acne or sebum-control formulas (different mechanism needed)
- Tinted SPF or color cosmetics (cost not justified)
- Formulas where the active is not protected from degradation
Frequently asked questions #
Can you combine EGF and FGF-2 in the same formula?
Yes. Because they act on different cell types, keratinocytes for EGF, fibroblasts for FGF-2, they are mechanistically complementary. Several products on the market pair them, and our own peauvita™ and peauforia™ are used together at 1% + 1% in published clinical work.
Is EGF or FGF-2 stronger?
Neither is universally stronger. EGF delivers faster visible barrier and texture improvements because the epidermis turns over in ~28 days. FGF-2 drives slower-developing but deeper changes in firmness and wrinkle depth because dermal remodeling takes weeks to months.
Are recombinant growth factors safe on the skin?
Recombinant EGF and FGF-2 have a strong dermatological safety record when produced at cosmetic grade and used at typical formulation concentrations (0.5 – 2%). Both have been HRIPT and patch tested as non-irritant and non-sensitizer in independent dermatologist-supervised studies.
Do EGF and FGF-2 work in over-the-counter skincare?
They work if they reach living cells. The limiting factor is delivery: free recombinant proteins are large molecules that do not cross the stratum corneum well on their own. Carrier systems such as oleosomes, liposomes, or covalent peptide tags materially improve bioavailability.
Should every skincare formula contain growth factors?
No. Growth factors are most useful for repair, recovery, anti-aging, and post-procedure formulas. They add limited value to cleansers, basic moisturizers, or formulas aimed at oil control, acne, or pure hydration.
For more on the platform behind these actives, see our technology overview, the launched products, or the full clinical evidence summary.